Global Information
회사소개 | 문의 | 비교리스트

세계의 심장 복원 시스템 시장(2019-2023년)

Global Cardiac Restoration Systems Market 2019-2023

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2019년 05월 상품 코드 851232
페이지 정보 영문 125 Pages
가격
US $ 2,500 ₩ 3,017,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,621,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,828,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,035,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 심장 복원 시스템 시장(2019-2023년) Global Cardiac Restoration Systems Market 2019-2023
발행일 : 2019년 05월 페이지 정보 : 영문 125 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

심혈관질환(CVD)은 관상동맥성 심장병, 뇌졸중, 말초동맥질환, 대동맥질환 등 심장이나 혈관에 영향을 미치는 질환의 총칭입니다. 심장이나 혈관에 지장을 가져오는 승모판 역류, 승모판 협착, 심부전 등의 증가가 심장 복원 시스템 시장의 성장을 촉진하고 있습니다. 세계 심장 복원 시스템 시장은 2023년까지 5% 이상의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계의 심장 복원 시스템(Cardiac Restoration System) 시장을 조사했으며, 시장 개요, 제품·최종사용자·지역별 시장 규모 추이와 예측, 시장 성장요인 및 과제, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 보고서의 범위

제3장 시장 상황

  • 시장 생태계
  • 시장 특성
  • 시장 세분화 분석

제4장 시장 규모

  • 시장 정의
  • 시장 규모
  • 시장 규모 및 예측

제5장 Five Forces 분석

  • 구매자의 협상력
  • 공급업체의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 현황

제6장 시장 세분화 : 제품별

  • 시장 세분화 : 제품별
  • 시장 비교 : 제품별
  • 승모판 복원 시스템
  • 좌심실 부전 복원 시스템
  • 시장 기회 : 제품별

제7장 시장 세분화 : 최종사용자별

  • 시장 세분화 : 최종사용자별
  • 시장 비교 : 최종사용자별
  • 병원
  • 외래수술센터
  • 기타
  • 시장 기회 : 최종사용자별

제8장 고객 상황

제9장 지역 상황

  • 시장 세분화 : 지역별
  • 시장 비교 : 지역별
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 시장 성장 기여국가
  • 시장 기회

제10장 의사결정 프레임워크

제11장 성장요인과 과제

  • 시장 성장요인
  • 시장의 과제

제12장 시장 동향

  • 조직을 이용한 승모판 복원 시스템 개발
  • 공학적 접근
  • 연구개발에 대한 큰 투자와 인수합병(M&A) 활동
  • 심장 복원 시스템의 인지도 향상

제13장 벤더 상황

  • 개요
  • 파괴적 혁신

제14장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Abbott
  • BioVentrix Inc.
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • NeoChord Inc.
  • Xeltis AG

제15장 부록

  • 조사 방법
  • 약어 리스트
  • 벤더의 시장 포지셔닝 정의

제16장 TECHNAVIO에 대해

LSH 19.05.30

About this market

CVDs are a class of diseases that affect the heart and blood vessels with conditions such as coronary heart disease, stroke, peripheral arterial disease, and aortic disease. They are usually caused due to the high risk of blood clots and fatty deposition in arteries. Blockage of the blood flow into the heart valve leads to regurgitation and stenosis. The increasing number of mitral valve regurgitation, mitral valve stenosis, and heart failure cases, where the heart cannot pump enough blood and oxygen to other parts of the body, is driving the market growth. Hence, the demand for cardiovascular restoration devices is expected to increase to treat the damaged and diseased heart valves, which, in turn, drives the market growth. Technavio's analysts have predicted that the cardiac restoration systems market will register a CAGR of over 5% by 2023.

Market Overview

Growing medical tourism in emerging economies

Medical tourism refers to patients traveling to countries such as Singapore, Malaysia, Thailand, and India to obtain medical treatment with high-quality healthcare, affordability, and accessibility benefits. Medical tourism is a booming industry, as each medical expertise is focused on offering niche services to attract foreign patients. The rise in quality of medical services and infrastructure in developing economies is a contributor to the growth of medical tourism, which propels the growth of the global cardiac restoration systems market during the forecast period.

Increasing number of product recalls

A product recall is a process of retrieving defective cardiac restoration systems from consumers with compensation. Product recalls tending to occur when there is a manufacturing defect in the product, which causes potential health-related risks to consumers. The increasing number of products recalls by manufacturers can slow down the launch of products in the market, affecting the sales and revenues of vendors, which, in turn, hinders the global cardiac restoration systems market growth.

For the detailed list of factors that will drive and challenge the growth of the cardiac restoration systems market during 2019-2023, view our report.

Competitive Landscape

The market appears to be fairly concentrated. The presence of few companies including Abbott and BioVentrix Inc., the competitive environment is quite intense. Vendors in the global cardiac restoration systems market are focused on implementing developmental strategies such as M&A and high R&D investments to improve their market share and expand their presence globally. CryoLife Inc., Edwards Lifesciences Corp., NeoChord Inc., and Xeltis AG are some of the major companies covered in this report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Mitral valve restoration systems - Market size and forecast 2018-2023
  • Left ventricular restoration systems - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • ASCs - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Development of mitral valve restoration systems with tissue
  • engineering approach
  • High R&D investments and M&A activities
  • Growing awareness about cardiac restoration systems

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • BioVentrix Inc.
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • NeoChord Inc.
  • Xeltis AG

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market characteristics analysis
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Mitral valve restoration systems - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Mitral valve restoration systems - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Left ventricular restoration systems - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Left ventricular restoration systems - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: End-user - Market share 2018-2023 (%)
  • Exhibit 26: Comparison by end-user
  • Exhibit 27: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: ASCs - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: ASCs - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Market opportunity by end-user
  • Exhibit 34: Customer landscape
  • Exhibit 35: Customer landscape analysis
  • Exhibit 36: Market share by geography 2018-2023 (%)
  • Exhibit 37: Geographic comparison
  • Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 41: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 43: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 44: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 45: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 46: Key leading countries
  • Exhibit 47: Market opportunity
  • Exhibit 48: Impact of drivers and challenges
  • Exhibit 49: Vendor landscape
  • Exhibit 50: Landscape disruption
  • Exhibit 51: Vendor landscape analysis
  • Exhibit 52: Vendors covered
  • Exhibit 53: Vendor classification
  • Exhibit 54: Market positioning of vendors
  • Exhibit 55: Abbott - Vendor overview
  • Exhibit 56: Abbott - Business segments
  • Exhibit 57: Abbott - Organizational developments
  • Exhibit 58: Abbott - Geographic focus
  • Exhibit 59: Abbott - Segment focus
  • Exhibit 60: Abbott - Key offerings
  • Exhibit 61: BioVentrix Inc. - Vendor overview
  • Exhibit 62: BioVentrix Inc. - Business segments
  • Exhibit 63: BioVentrix Inc. - Key offerings
  • Exhibit 64: CryoLife Inc. - Vendor overview
  • Exhibit 65: CryoLife Inc. - Product segments
  • Exhibit 66: CryoLife Inc. - Organizational developments
  • Exhibit 67: CryoLife Inc. - Geographic focus
  • Exhibit 68: CryoLife Inc. - Segment focus
  • Exhibit 69: CryoLife Inc. - Key offerings
  • Exhibit 70: Edwards Lifesciences Corp. - Vendor overview
  • Exhibit 71: Edwards Lifesciences Corp. - Product segments
  • Exhibit 72: Edwards Lifesciences Corp. - Organizational developments
  • Exhibit 73: Edwards Lifesciences Corp. - Geographic focus
  • Exhibit 74: Edwards Lifesciences Corp. - Segment focus
  • Exhibit 75: Edwards Lifesciences Corp. - Key offerings
  • Exhibit 76: NeoChord Inc. - Vendor overview
  • Exhibit 77: NeoChord Inc. - Business segments
  • Exhibit 78: NeoChord Inc. - Key offerings
  • Exhibit 79: Xeltis AG - Vendor overview
  • Exhibit 80: Xeltis AG - Business segments
  • Exhibit 81: Xeltis AG - Key offerings
  • Exhibit 82: Validation techniques employed for market sizing
  • Exhibit 83: Definition of market positioning of vendors
Back to Top
전화 문의
F A Q